Targeting TOR dependence in cancer.
- Author(s): Janes, Matthew R;
- Fruman, David A
- et al.
Published Web Locationhttps://doi.org/10.18632/oncotarget.110
A challenge in cancer therapy has been to identify targets whose function is essential for survival of malignant cells but not normal cells. This Perspective discusses recent evidence that novel inhibitors of the kinase TOR can provide an unprecedented balance of anti-cancer efficacy and tolerability.